Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionCcg Wealth Management, Llc
Latest Disclosed Ownership2,154 shares
Latest Disclosed Value $ 221,178
Ccg Wealth Management, Llc reports 16.18% increase in ownership of ABL / Abbott Laboratories

On April 8, 2026 - Ccg Wealth Management, Llc filed a 13F-HR form disclosing ownership of 2,154 shares of Abbott Laboratories (DE:ABL) valued at $191,318 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 1,854 shares of Abbott Laboratories. This represents a change in shares of 16.18% during the quarter. The current value of the position is $162,024 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-08 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 2,154 300 16.18 221 -4.74 0.0600
2026-01-21 2025-12-31 13F ABBOTT LABS COM 002824100 1,854 1,854 232 0.0996
2023-04-12 2023-03-31 13F ABBOTT LABS COM 002824100 0 -3,762 -100.00 0 -100.00
2023-01-19 2022-12-31 13F ABBOTT LABS COM 002824100 3,762 163 4.53 413 18.68 0.2294
2022-10-18 2022-09-30 13F ABBOTT LABS COM 002824100 3,599 83 2.36 348 -8.90 0.2125
2022-07-15 2022-06-30 13F ABBOTT LABS COM 002824100 3,516 638 22.17 382 12.02 0.2152
2022-04-12 2022-03-31 13F ABBOTT LABS COM 002824100 2,878 1,012 54.23 341 29.66 0.1671
2022-01-20 2021-12-31 13F ABBOTT LABS COM 002824100 1,866 0 0.00 263 19.55 0.1371
2021-10-26 2021-09-30 13F ABBOTT LABS COM 002824100 1,866 0 0.00 220 1.85 0.1274
2021-07-16 2021-06-30 13F ABBOTT LABS COM 002824100 1,866 -128 -6.42 216 -9.62 0.1678
2021-05-04 2021-03-31 13F ABBOTT LABS COM 002824100 1,994 -11 -0.55 239 8.64 0.2355
2021-02-04 2020-12-31 13F ABBOTT LABS COM 002824100 2,005 131 6.99 220 7.84 0.2319
2020-11-10 2020-09-30 13F ABBOTT LABS COM 002824100 1,874 -335 -15.17 204 0.99 0.1911
2020-08-04 2020-06-30 13F ABBOTT LABS COM 002824100 2,209 -2,033 -47.93 202 -39.70 0.1883
2020-04-24 2020-03-31 13F ABBOTT LABS COM 002824100 4,242 8 0.19 335 -8.97 0.3217
2020-01-30 2019-12-31 13F ABBOTT LABS COM 002824100 4,234 7 0.17 368 3.95 0.2329
2019-11-14 2019-09-30 13F ABBOTT LABS COM 002824100 4,227 4,227 354 0.2414
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.